News

Teva launches authorized generic Actos

BY Allison Cerra

JERUSALEM — Teva Pharmaceutical Industries announced the launch of an authorized generic of a Type 2 diabetes drug.

The company launched pioglitazone hydrochloride tablets in the 15-mg, 30-mg and 45-mg strengths. The drug is a generic version of Takeda Pharmaceuticals’ Actos.

Annual sales of Actos in the United States were approximately $2.7 billion for the 12-month period ended in June, according to IMS sales data.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Ranbaxy launches authorized generic diabetes drug

BY Alaric DeArment

PRINCETON, N.J. — Ranbaxy Labs has launched an authorized generic version of a diabetes drug made by Takeda Pharmaceutical, Ranbaxy said Friday.

Ranbaxy announced the launch, through subsidiary Ranbaxy Pharmaceuticals and under an agreement with Takeda, of pioglitazone hydrochloride tablets, an authorized generic version of Takeda’s Actos. An authorized generic is a branded drug marketed at a reduced price under its generic name, typically by a third-party company operating under contract with the original branded drug’s manufacturer.

Actos, used to treat Type 2 diabetes, had sales of $2.7 billion during the 12-month period ended in June, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Better health doesn’t just happen at Walgreens, it happens through Walgreens

BY Michael Johnsen

WHAT IT MEANS AND WHY IT’S IMPORTANT — Even just a few years ago, this kind of collaboration between a healthcare group and a drug store around a comprehensive food nutrition education program probably wouldn’t have happened. Truth be told, it really isn’t happening today. And that’s because Walgreens isn’t a drug store. Walgreens is a health and daily living solutions store.

(THE NEWS: Walgreens teams with University of Chicago Medicine on South Side Food Rx initiative. For the full story, click here.)

And whenever you talk about Walgreens and its "health and daily living solutions" motto, it’s usually with the customer in mind. But more and more, Walgreens has expanded the reach of that motto to incorporate healthcare groups both private and public, because health and daily living solutions don’t just happen at a Walgreens location, they happen through a Walgreens location.

More important than the transformation happening across Walgreens that is enabling such partnerships as this is the potential impact these partnerships will have on the community. According to the Institute for Alternative Futures’ diabetes model estimates for the Chicago metropolitan statistical area, people living with diabetes (both diagnosed and undiagnosed) will increase by 46% by 2025 to 1.7 million people from a 2010 base of 1.1 million. The resulting medical and societal cost of diabetes will be $15.9 billion, a 54% increase from 2010.

Here is how the IAF projections break down across the Chicago MSA:

  • Number of people with prediabetes in 2010 totaled 2.5 million; in 2025, that will reach 2.6 million;

  • Diagnosed diabetes cases in 2010 totaled 711,800; in 2025, that will reach 1.2 million;

  • Undiagnosed diabetes cases in 2010 totaled 420,800; in 2025, that will reach 449,100;

  • Visual impairment associated with diabetes totaled 128,800 in 2010; in 2025, that will reach 207,300; and

  • Annual deaths attributable to diabetes totaled 10,340 in 2010; in 2025, that will reach 13,740.

"If 50% of people with prediabetes successfully made these lifestyle changes, [including modest weight loss and increase in regular physical activity], it could reduce the number of new cases of diabetes in the Chicago MSA by about 10,400 a year," the IAF said. "Between [2010] and 2025, that would be a reduction of about 135,600 people with diabetes with a cumulative savings of about $8.6 billion."

IAF continued: "Halting the ‘twin epidemics’ of diabetes and obesity will require fundamental change in all segments of society, including greater access to opportunities for physical activity in our schools, workplaces and communities, and a signficant shift in the American diet away from sugar, salt, refined carbohydrates and saturated fats and toward more fruits and vegetables."

Sound familiar? Because that’s what Walgreens and other retailers are enabling when they extend their "fresh" programs into urban areas where there just aren’t that many fruit and vegetable options. That’s what Walgreens is enabling when it encourages and rewards its patient base to exercise more as part of its "Walk with Walgreens" program. And that’s what Walgreens and the University of Chicago Medicine are enabling when they partner on a nutrition education program.

If half of people with prediabetes successfully make lifestyle changes because of programs like this, that will be 1,125 saved lives by 2025. And that’s just in the Chicago MSA.

That’s what makes this pretty important.

What do you think? Sound off in the comments below.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES